|
| | Publication Year | Title | Author(s) |
| 21 | 2023 | Augmented ICE in Patients With Poor-Risk Refractory and Relapsed Lymphomas. | Loo, Sun; Lim, Andrew Boon Ming ; Lee, Sze Ting ; Grigg, Andrew P |
| 22 | Dec-2020 | Australasian Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in the Molecular Era: A retrospective analysis from The Australasian Bone Marrow Transplant Recipient Registry. | Lwin, Yadnar; Kennedy, Glenn; Gottlieb, David; Kwan, John; Ritchie, David; Szer, Jeff; Milliken, Samuel; Browett, Peter; Spencer, Andrew; Butler, Andrew; Bardy, Peter; Greenwood, Matthew; Perera, Travis ; He, Simon ; McEwan, Ashley; Larsen, Stephen; Lai, Hock; Purtill, Duncan; Tran, Steven ; Aarons, Donna; Hamad, Nada |
| 23 | Aug-2021 | Australia and New Zealand Transplant and Cellular Therapies COVID-19 vaccination consensus position statement. | Hamad, Nada; Ananda-Rajah, Michelle; Gilroy, Nicole; MacIntyre, Raina; Gottlieb, David; Ritchie, David; Harrison, Simon; Kennedy, Glen; Watson, Anne M; Greenwood, Matthew; Doocey, Richard; Perera, Travis; Spencer, Andrew; Wong, Eric ; O'Brien, Tracey; Shaw, Peter; Conyers, Rachel; Milliken, Samuel; Bardy, Peter; Larsen, Stephen; Ho, Phoebe J; Lai, Hock; Bajel, Ashish; Butler, Jason; Tiley, Campbell; D'Rozario, James; Johnston, Anna; Cochrane, Tara; Mills, Tony; Irving, Ian; Pullon, Humprey; Purtill, Duncan |
| 24 | 12-Aug-2023 | Author gender representation of journal reviews and editorials on lymphoma (2017-22). | Hawkes, Eliza A ; Trotman, Judith; Casulo, Carla; Smith, Sonali M; LaCasce, Ann |
| 25 | Nov-2018 | Author reply. | Hong, Frank S; Mo, Allison ; Nasra, Faye; Sieradzki, Nicole; Pollock, Claire; Willcox, Abbey ; Smith, Carole; Khoon, Wai |
| 26 | 30-Mar-2014 | Autologous is superior to allogeneic hematopoietic cell transplantation for acute promyelocytic leukemia in second complete remission. | Holter Chakrabarty, Jennifer L; Rubinger, Morel; Le-Rademacher, Jennifer; Wang, Hai-Lin; Grigg, Andrew P ; Selby, George B; Szer, Jeffrey; Rowe, Jacob M; Weisdorf, Daniel J; Tallman, Martin S |
| 27 | 2021 | Avelumab in Combination Regimens for Relapsed/Refractory DLBCL: Results from the Phase Ib JAVELIN DLBCL Study. | Hawkes, Eliza A ; Phillips, Tycel; Budde, Lihua Elizabeth; Santoro, Armando; Saba, Nakhle S; Roncolato, Fernando; Gregory, Gareth P; Verhoef, Gregor; Offner, Fritz; Quero, Cristina; Radford, John; Giannopoulos, Krzysztof; Stevens, Don; Thall, Aron; Huang, Bo; Laird, A Douglas; Sandner, Robin; Ansell, Stephen M |
| 28 | 2019 | Azacitidine with or without lenalidomide in higher risk myelodysplastic syndrome & low blast acute myeloid leukemia. | Kenealy, Melita; Hertzberg, Mark; Benson, Warwick; Taylor, Kerry; Cunningham, Ilona; Stevenson, Will; Hiwase, Devendra; Eek, Richard; Zantomio, Daniela ; Jong, Steve; Wall, Meaghan; Blombery, Piers; Gerber, Tracey; Debrincat, Marlyse; Zannino, Diana; Seymour, John F |
| 29 | 3-Mar-2023 | Bendamustine plus rituximab for the treatment of Waldenström Macroglobulinaemia: patient outcomes and impact of bendamustine dosing. | Arulogun, Suzanne O; Brian, Duncan; Goradia, Harshita; Cooney, Aaron; Menne, Tobias; Koo, RayMun; O'Neill, Aideen T; Vos, Josephine M I; Pratt, Guy; Turner, Deborah; Marshall, Kirsty; Manos, Kate ; Anderson, Claire; Gavriatopoulou, Maria; Kyriakou, Charalampia; Kersten, Marie J; Minnema, Monique C; Koutoumanou, Eirini; El-Sharkawi, Dima; Linton, Kim; Talaulikar, Dipti; McCarthy, Helen; Bishton, Mark; Follows, George; Wechalekar, Ashutosh; D'Sa, Shirley P |
| 30 | 1-Aug-1989 | Bleeding due to an acquired inhibitor of platelet associated factor V. | Grigg, Andrew P ; Dauer, R; Thurlow, P J |
| 31 | Jun-2020 | Bone Marrow Transplant Society of Australia and New Zealand COVID-19 consensus position statement. | Hamad, Nada; Gottlieb, David; Ritchie, David; Kennedy, Glen; Watson, Anne M; Greenwood, Matthew; Doocey, Richard; Perera, Travis; Spencer, Andrew; Wong, Eric ; O'Brien, Tracey; Shaw, Peter; Conyers, Rachel; Cole, Theresa; Milliken, Sam; Bardy, Peter; Larsen, Stephen; Lai, Hock; Butler, Andrew; Fraser, Chris; Bajel, Ashish; Butler, Jason; Kerridge, Ian; Purtill, Duncan |
| 32 | 15-Dec-2020 | Bottom-of-sulcus dysplasia: the role of 18F-FDG PET in identifying a focal surgically remedial epileptic lesion. | Berlangieri, Salvatore U ; Mito, R; Semmelroch, M; Pedersen, M; Jackson, G |
| 33 | 5-Oct-2023 | Brentuximab vedotin with chemotherapy in adolescents and young adults with stage III or IV classical Hodgkin lymphoma in ECHELON-1. | Crosswell, Howland E; LaCasce, Ann S; Bartlett, Nancy L; Straus, David J; Savage, Kerry J; Zinzani, Pier Luigi; Collins, Graham P; Fanale, Michelle; Fenton, Keenan; Dong, Cassie; Miao, Harry; Grigg, Andrew P |
| 34 | Jan-2017 | Busulfan is effective second-line therapy for older patients with Philadelphia-negative myeloproliferative neoplasms intolerant of or unresponsive to hydroxyurea | Douglas, Genevieve ; Harrison, Claire; Forsyth, Cecily J; Bennett, Michael R; Stevenson, William; Hounsell, John; Ratnasingam, Sumita; Ritchie, David; Ross, David M; Grigg, Andrew P |
| 35 | 10-Dec-2020 | Can PET eradicate irradiation in PMBCL? | Hawkes, Eliza A |
| 36 | 14-Jun-2022 | Cancer-related cognitive impairment in patients with newly diagnosed aggressive lymphoma undergoing standard chemotherapy: a longitudinal feasibility study. | Gates, Priscilla ; Krishnasamy, Meinir; Wilson, Carlene J ; Hawkes, Eliza A ; Doré, Vincent ; Perchyonok, Yuliya ; Rowe, Christopher C ; Walker, Adam K; Vardy, Janette L; de Ruiter, Michiel B; Cushion, Tania; Dhillon, Haryana M; Gough, Karla |
| 37 | Nov-2020 | Case Report: Confirmation by Metagenomic Sequencing of Visceral Leishmaniasis in an Immunosuppressed Returned Traveler. | Williams, Eloise; Isles, Nicole S; Seemann, Torsten; Kilpatrick, Trevor; Grigg, Andrew P ; Leroi, Marcel J ; Howden, Benjamin P ; Kwong, Jason C |
| 38 | 26-Oct-2020 | Caution in Expanding the Use of Abbreviated R-CHOP to Poor-Risk Limited-Stage DLBCL. | Hawkes, Eliza A ; Opat, Stephen; Hertzberg, Mark |
| 39 | 1-Dec-2015 | Cellular mechanisms underlying complete hematological response of chronic myeloid leukemia to BRAF and MEK1/2 inhibition in a patient with concomitant metastatic melanoma | Andrews, Miles C; Turner, Natalie; Boyd, Janis; Roberts, Andrew W; Grigg, Andrew P ; Behren, Andreas; Cebon, Jonathan S |
| 40 | 1-Oct-2017 | Central nervous system relapse of diffuse large B-cell lymphoma in the rituximab era: results of the UK NCRI R-CHOP-14 versus 21 trial. | Gleeson, M; Counsell, Nicholas; Cunningham, D; Chadwick, N; Lawrie, A; Hawkes, Eliza A ; McMillan, A; Ardeshna, K M; Jack, A; Smith, P; Mouncey, P; Pocock, C; Radford, J A; Davies, J; Turner, D; Kruger, A; Johnson, P ; Gambell, J; Linch, D |
